Six-year follow up of silodosin monotherapy for the treatment of lower urinary tract symptoms suggestive of benign prostatic hyperplasia: What are the factors for continuation or withdrawal?
2015 ◽
Vol 22
(12)
◽
pp. 1143-1148
◽
2016 ◽
Vol 11
(1)
◽
pp. 164-169
◽